Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer - predictors of response and impact of previous radiotherapy.
Åsa Kristina ÖjlertDaniel NebdalMarius Lund-IversenRenée Åstrøm EllefsenOdd Terje BrustugunJon Michael GranAnn Rita HalvorsenÅslaug HellandPublished in: Acta oncologica (Stockholm, Sweden) (2020)
Radiotherapy may be of importance to achieve a long-lasting response to immunotherapy, while indicators of systemic inflammation can help in identifying patients with poor short-term prognosis.